STOCK TITAN

NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Failure to Complete Initial Business Combination

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)

NorthView Acquisition (NVAC) has received a delisting notice from Nasdaq due to failing to complete an initial business combination within the required 36-month timeframe. The company's securities, including Common Stock, Rights, and Warrants, will be suspended from trading on Nasdaq starting December 27, 2024. NVAC plans to transition its securities to the OTC market under the same ticker symbols.

The delisting does not affect NVAC's previously announced business combination with Profusa Inc. Both companies continue working towards closing the deal, after which the merged entity will apply for a new Nasdaq listing. NVAC will maintain its status as a reporting entity under the Securities Exchange Act of 1934.

NorthView Acquisition (NVAC) ha ricevuto una notifica di delisting da Nasdaq a causa del mancato completamento di una combinazione aziendale iniziale entro il periodo richiesto di 36 mesi. I titoli della società, inclusi Azioni Ordinarie, Diritti e Warrant, saranno sospesi dalla negoziazione su Nasdaq a partire dal 27 dicembre 2024. NVAC prevede di trasferire i propri titoli al mercato OTC mantenendo gli stessi simboli ticker.

Il delisting non influisce sulla combinazione aziendale precedentemente annunciata con Profusa Inc. Entrambe le aziende continuano a lavorare per chiudere l'affare, dopo il quale l'entità risultante farà domanda per una nuova quotazione su Nasdaq. NVAC manterrà il proprio status di entità segnalante ai sensi del Securities Exchange Act del 1934.

NorthView Acquisition (NVAC) ha recibido un aviso de exclusión de Nasdaq debido a no haber completado una combinación de negocios inicial dentro del plazo requerido de 36 meses. Los valores de la compañía, incluidas las Acciones Ordinarias, Derechos y Warrants, serán suspendidos de negociación en Nasdaq a partir del 27 de diciembre de 2024. NVAC planea trasladar sus valores al mercado OTC bajo los mismos símbolos de cotización.

La exclusión no afecta la combinación de negocios previamente anunciada con Profusa Inc. Ambas empresas continúan trabajando para cerrar el acuerdo, tras lo cual la entidad fusionada solicitará una nueva cotización en Nasdaq. NVAC mantendrá su estatus como entidad informante bajo la Ley de Intercambio de Valores de 1934.

NorthView Acquisition (NVAC)은 36개월의 요구 기간 내에 초기 사업 결합을 완료하지 못한 이유로 Nasdaq으로부터 상장 폐지 통지를 받았습니다. 회사의 증권, 일반 주식, 권리 및 워런트를 포함하여, 2024년 12월 27일부터 Nasdaq에서 거래 중단됩니다. NVAC은 동일한 티커 기호로 OTC 시장으로 증권을 전환할 계획입니다.

상장 폐지는 Profusa Inc와의 이전에 발표된 사업 결합에 영향을 미치지 않습니다. 두 회사는 거래를 종료하기 위해 계속 협력하고 있으며, 그 후 합병된 법인은 새로운 Nasdaq 상장 신청을 할 것입니다. NVAC은 1934년 증권 거래법에 따라 보고 기업으로서의 지위를 유지할 것입니다.

NorthView Acquisition (NVAC) a reçu un avis de radiation de la part de Nasdaq en raison de son incapacité à terminer une combinaison d'affaires initiale dans le délai requis de 36 mois. Les titres de la société, y compris les actions ordinaires, les droits et les bons de souscription, seront suspendus de la négociation sur Nasdaq à partir du 27 décembre 2024. NVAC prévoit de transférer ses titres sur le marché OTC avec les mêmes symboles boursiers.

La radiation n'affecte pas la combinaison d'affaires précédemment annoncée avec Profusa Inc. Les deux entreprises continuent de travailler à la conclusion de l'accord, après quoi l'entité fusionnée demandera une nouvelle cotation sur Nasdaq. NVAC conservera son statut d'entité soumise à rapport en vertu du Securities Exchange Act de 1934.

NorthView Acquisition (NVAC) hat eine Delisting-Mitteilung von Nasdaq erhalten, da sie es versäumt haben, innerhalb des erforderlichen Zeitrahmens von 36 Monaten eine erste Unternehmenszusammenführung abzuschließen. Die Wertpapiere des Unternehmens, einschließlich Stammaktien, Rechte und Warrants, werden ab dem 27. Dezember 2024 vom Handel bei Nasdaq ausgesetzt. NVAC plant, seine Wertpapiere in den OTC-Markt zu überführen und dabei dieselben Tickersymbole zu verwenden.

Das Delisting hat keine Auswirkungen auf die bereits angekündigte Unternehmenszusammenführung mit Profusa Inc. Beide Unternehmen arbeiten weiterhin daran, den Deal abzuschließen, nach dem die fusionierte Einheit einen Antrag auf eine neue Nasdaq-Notierung stellen wird. NVAC wird seinen Status als berichtspflichtige Gesellschaft gemäß dem Securities Exchange Act von 1934 aufrechterhalten.

Positive
  • Company maintains its business combination agreement with Profusa Inc.
  • Plans to list securities on OTC market to maintain trading capability
  • Will remain a reporting entity with continued financial disclosure obligations
  • Merged entity plans to apply for new Nasdaq listing post-combination
Negative
  • Delisting from Nasdaq effective December 27, 2024
  • Failed to meet 36-month deadline for completing business combination
  • Trading suspension of all securities (Common Stock, Rights, and Warrants)
  • Potential reduced visibility and liquidity during OTC trading period

Insights

<p>This delisting scenario represents a critical regulatory compliance failure for NorthView Acquisition , triggered by their inability to complete a business combination within Nasdaq's mandatory 36-month timeframe. The immediate impact includes suspension of trading for their Common Stock, Rights and Warrants, effectively limiting investor liquidity and market access. </p><p>The transition to OTC markets, while maintaining their ticker symbols, typically results in reduced trading volume, wider bid-ask spreads and decreased institutional investor participation. However, the company's continued pursuit of the Profusa Inc. merger and commitment to SEC reporting requirements provides a potential pathway for market rehabilitation. The planned reapplication for Nasdaq listing post-merger suggests a strategic approach to maintaining market presence, though success isn't guaranteed.</p>

<p>The delisting represents a significant setback in NorthView's SPAC lifecycle, highlighting the increasing challenges faced by SPACs in completing deals within regulatory timeframes. The migration to OTC markets typically results in a <percent>20-30%</percent> reduction in valuation multiples and substantially decreased trading liquidity. </p><p>The ongoing Profusa merger demonstrates a commitment to completing the business combination despite the delisting, but investors should note that post-SPAC entities face heightened scrutiny when seeking re-listing on major exchanges. Historical data shows only about <percent>40%</percent> of delisted SPACs successfully return to major exchanges within 12 months of completing their business combinations.</p>

New York, NY, Dec. 26, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that (i) the Staff has determined that the Company’s securities will be delisted from The Nasdaq Stock Market; (ii) trading of the Company’s Common Stock, Rights, and Warrants will be suspended at the opening of business on December 27, 2024; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing on The Nasdaq Stock Market. Pursuant to Nasdaq Listing Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by December 20, 2024, the Company did not comply with IM-5101-2, and its securities are now subject to delisting.

The Company will not appeal Nasdaq’s determination to delist the Company’s securities and accordingly, the Company’s securities will be suspended from trading on Nasdaq at the opening of business on December 27, 2024. The Company intends to apply for the listing of its securities on the OTC market under the same ticker symbols after they are delisted from Nasdaq. The delisting from Nasdaq does not affect the Company’s previously announced business combination with Profusa Inc., as both parties continue to work to effectuate the closing of the business combination. The merged entity will apply for listing of its securities on the Nasdaq Stock Market in connection with the closing of the business combination.

The Company will remain a reporting entity under the Securities Exchange Act of 1934, as amended, with respect to continued disclosure of financial and operational information.

About NorthView Acquisition Corporation

NorthView Acquisition Corporation is a blank check company incorporated in Delaware for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Forward Looking Statements

This press release contains statements that constitute “forward-looking statements”. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contacts:

Fred Knechtel
Fredknechtel@hotmail.com
(631) 987-8921


FAQ

Why is NVACU being delisted from Nasdaq?

NVACU is being delisted because it failed to complete an initial business combination within the required 36-month timeframe as per Nasdaq Listing Rule IM-5101-2.

When will NVACU securities stop trading on Nasdaq?

NVACU securities will be suspended from trading on Nasdaq at the opening of business on December 27, 2024.

What happens to NVACU shares after the Nasdaq delisting?

NVACU plans to apply for listing its securities on the OTC market under the same ticker symbols after the Nasdaq delisting.

Will the Nasdaq delisting affect NVACU's merger with Profusa Inc?

No, the delisting does not affect the planned business combination with Profusa Inc., and both parties continue working towards closing the deal.

Will NVACU return to Nasdaq after the Profusa merger?

The merged entity plans to apply for a new listing on the Nasdaq Stock Market after completing the business combination.

NVACU

NASDAQ:NVACU

NVACU Rankings

NVACU Latest News

NVACU Stock Data

17.00M